ON DEMAND WEBINAR
Duration: 60 minutes​

At Accolade, we strive to strike a balance between clinical considerations and employee welfare. Most recently, this means potentially addressing the obesity epidemic with a new class of drugs - GLP-1s. 

HR leaders and plan sponsors face several questions and unknowns regarding how they will address GLP-1s in their strategic benefit plan offerings. This may be the most important benefit plan change to consider this year: How to prioritize employee health while managing pharmacy spend, defining successful outcomes and having guardrails around who is eligible for coverage.

Obesity is a serious health issue requiring real, tangible support. It's time to move beyond the traditional boundaries of healthcare benefits and create a supportive and inclusive environment for all employees. Join our interactive discussion to learn more about:

• The clinical and financial aspects of GLP-1s
• How to effectively address this pressing issue
• Fostering a culture of health and well-being in our workplaces

SPEAKERS

James Wantuck, MD
Associate Chief Medical Officer
Accolade & PlushCare

Nancy Costlow PharmD, BCSCP, PRS, RPh
Sr. Director, Clinical Shared Services
Accolade

Jennifer Hanson, JD
Executive Vice President, Chief Human Resource Officer
Accolade